1. Scrip
  2. >>R&D

Merck KGaA, Aragen Execs On AI-Led Drug Discovery, Incubator Set-up, US Tariffs And More

Goldman Sachs Investee Seeks Further Funding

 
• By Vibha Ravi

Merck’s India head for process solutions and Aragen Bioscience’s CEO talk about an incubator set-up and AI-led drug discovery to enable India’s research ecosystem, US tariffs on China, ADC and GLP-1 development, funding path for Goldman Sachs-investee Aragen and more in this video interview

Merck Head Aditya Sharma Aragen CEO Subodh Deshmukh With Citeline's Vibha Ravi
Merck Life Head Aditya Sharma And Aragen CEO Subodh Deshmukh In An Interview With Citeline (Citeline Scrip)

Merck KGaA’s artificial intelligence software for drug discovery is finding its way to Indian start-ups with the company’s process solutions vertical extending a helping hand.

In a wide-ranging video interview with Scrip, Merck Life Science’s India process solutions head, Aditya Sharma and Aragen Bioscience CEO,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Manufacturing